Filing Flows › Eton Pharmaceuticals (ETON) › How it makes money
How Eton Pharmaceuticals (ETON) makes money
Eton Pharmaceuticals (ETON) made $57.9M of revenue in the third quarter 2026 (Q3 2026), +158% from a year earlier. Of every dollar of revenue, 76¢ was left as gross profit, 40¢ was left as operating profit, 61¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $57.9M | 100.0% |
| Cost of revenue | $13.6M | 23.5% |
| Gross profit | $44.3M | 76.5% |
| Operating expenses | $21.3M | 36.8% |
| Operating profit | $23.0M | 39.7% |
| Net earnings | $35.2M | 60.9% |
| Operating cash flow | $35.2M | 60.8% |
| Free cash flow | $35.2M | 60.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $57.9M | +158% |
| Q2 2026 | $37.6M | +99% |
| Q1 2026 | $24.3M | +40% |
| Q4 2025 | $21.3M | +83% |
| Q3 2025 | $22.5M | +118% |
| Q2 2025 | $18.9M | +109% |
| Q1 2025 | $17.3M | +117% |
From Eton Pharmaceuticals' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Eton Pharmaceuticals make money?
Eton Pharmaceuticals (ETON) made $57.9M of revenue in the third quarter 2026 (Q3 2026), +158% from a year earlier. Of every dollar of revenue, 76¢ was left as gross profit, 40¢ was left as operating profit, 61¢ was left as net earnings.
What is Eton Pharmaceuticals' profit margin?
Net earnings were $35.2M, 60.9% of revenue, in the third quarter 2026; the operating margin was 39.7%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.